The bid covers adults with BMI 30 or more, heart patients and teens. Korea's customs service caught 5,030 illegal obesity drug imports this year.
Recap by typeshit. Full story at Korea Biomedical Review.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
A new episode of the In Discussion With series looks at the pace of weight loss on GLP-1 receptor agonists.
Exposures nearly doubled from 460 the quarter before, and the FDA got two death reports it hasn't verified. Lilly says it has referred over 200 sellers to regulators.
Loading…